Kaptein A, Paillard V, Saunders M
Laboratoires Glaxo-Wellcome, Centre de Recherche, ZA de Courtaboeuf, France.
J Biol Chem. 1996 Mar 15;271(11):5961-4. doi: 10.1074/jbc.271.11.5961.
Interleukin-6 (IL-6) induces tyrosine phosphorylation and activation of the latent transcription factor Stat3 in HepG2 cells. Mutation of Stat3 tyrosine 705 to phenylalanine (Y705F) inhibits IL-6-induced tyrosine phosphorylation of this Stat3 mutant in transfected HepG2 cells. In cotransfections of HepG2 cells, the Stat3 mutant Y705F causes a reduction of the tyrosine phosphorylation of wild type Stat3-FLAG. Moreover, Y705F inhibits the action of endogenous Stat3 in cotransfected cells, reducing IL-6 induction of a Stat3-responsive reporter construct. Y705F therefore acts as a dominant negative mutation of Stat3.
白细胞介素-6(IL-6)可诱导HepG2细胞中潜伏转录因子Stat3的酪氨酸磷酸化并激活。将Stat3的酪氨酸705突变为苯丙氨酸(Y705F)可抑制转染的HepG2细胞中该Stat3突变体的IL-6诱导的酪氨酸磷酸化。在HepG2细胞的共转染中,Stat3突变体Y705F导致野生型Stat3-FLAG的酪氨酸磷酸化减少。此外,Y705F抑制共转染细胞中内源性Stat3的作用,降低Stat3反应性报告基因构建体的IL-6诱导。因此,Y705F作为Stat3的显性负性突变起作用。